October 3, 2024 Insights from ECTRIMS 2024: Exploring MS Biomarkers and the Role of Quanterix read more
March 29, 2024 Breaking Ground in Alzheimer’s Diagnosis: Simoa® p-Tau 217 Blood Test Receives FDA Breakthrough Device Designation read more
March 14, 2024 Advancing Alzheimer’s Disease Pathology Detection with Simoa® ALZpath p-Tau217 Assay read more
February 15, 2024 Advances in Blood-Based Biomarkers for Alzheimer’s and Parkinson’s Diseases read more
February 13, 2024 CSF p-Tau 205 Emerges as a Biomarker of Tau Pathology in Alzheimer’s Disease read more